Microtubule/Tubulin

2-Methylthiophenothiazine is a potent tubulin inhibitor known for its ability to disrupt microtubule dynamics. This compound has demonstrated potential anticancer activity by inhibiting tubulin aggregation, which may ultimately affect cell proliferation and survival. It is a valuable tool for research into cancer biology and for studies focusing on microtubule-targeting therapeutics.

T900607 is a microtubule inhibitor that disrupts microtubule polymerization, thereby exerting its anti-tumor effects. This compound has demonstrated significant potential in cancer research by inducing cell cycle arrest and apoptosis in various tumor cell lines. Its mechanism of action is valuable for investigating microtubule dynamics and exploring therapeutic strategies for cancer treatment.

Tubulin polymerization-IN-74 is a potent inhibitor of tubulin polymerization, exhibiting an IC50 value of 15 μM. This compound is utilized predominantly in anticancer research, providing valuable insights into microtubule dynamics and their role in cancer cell proliferation. Its inhibition of tubulin assembly makes it a valuable tool for studying pathways related to tumorigenesis and therapeutic strategies targeting cytoskeletal components.

Bifidenone is a potent inhibitor of tubulin polymerization, demonstrating significant antiproliferative effects across various human cancer cell lines. This compound's mechanism of action disrupts microtubule dynamics, making it a valuable tool for cancer research. Bifidenone is useful for investigating cellular processes related to mitosis and offers potential insights into therapeutic strategies targeting tumor cell proliferation.

3,4',5-Trismethoxybenzophenone is a potent inhibitor of tubulin assembly, exhibiting an IC50 value of 2.6 µM. This compound disrupts microtubule polymerization, making it a valuable tool for studying cellular processes and the cytoskeleton. Its application ranges from investigating cancer biology to exploring mechanisms of drug resistance.

Monomethyl auristatin E intermediate-6 serves as a crucial intermediate reagent in the synthesis of Monomethyl auristatin E (MMAE), a potent microtubule/tubulin inhibitor with established anticancer properties. MMAE is recognized for its application as the cytotoxic component in antibody-drug conjugates (ADCs), facilitating targeted cancer therapies. This intermediate is essential for research focused on developing effective ADCs and exploring microtubule dynamics in oncology.

Monomethyl auristatin E intermediate-17 serves as a crucial intermediate reagent in the synthesis of Monomethyl auristatin E (MMAE), a potent microtubule/tubulin inhibitor with significant anticancer activity. MMAE is prominently utilized as the cytotoxic agent in antibody-drug conjugates (ADCs), facilitating targeted cancer therapies. The development and study of this intermediate are essential for advancing ADC research and optimizing therapeutic efficacy.

Monomethyl auristatin E intermediate-5 is an essential intermediate reagent in the synthesis of Monomethyl auristatin E (MMAE), a potent microtubule/tubulin inhibitor recognized for its anticancer activity. MMAE serves as a key cytotoxic component in antibody-drug conjugates (ADCs), which are increasingly utilized in targeted cancer therapies. The utility of this intermediate supports the development of innovative ADC strategies for effective cancer treatment.

N-Boc-dolaproine-amide-Me-Phe is a derivative of the amino acid residue found in the pentapeptide Dolastatin 10, which primarily targets tubulin polymerization. This compound exhibits significant antitumor activity through its inhibition of mitosis. It is suitable for research applications focused on cancer biology and the study of microtubule dynamics.

NSC 145669 is a potent inhibitor of tubulin polymerization, demonstrating an IC50 of 1.7 μM. This compound exhibits significant cytotoxic effects on various cancer cell lines and has shown promising antileukemic activity in murine models. NSC 145669 serves as a valuable tool for research focused on cancer biology, particularly in the study of microtubule dynamics and therapeutic strategies targeting tubulin.

N-Deacetylcolchicine is a potent inhibitor of microtubule polymerization, exhibiting an IC50 of 3 μM against bovine brain microtubules. As a derivative of colchicine, it effectively activates the GTPase activity of microtubules, making it valuable for research related to cancer biology and treatment mechanisms. This compound offers significant potential for studies focusing on microtubule dynamics and their role in cancer cell proliferation.